Brussels, 03/08/2004 (Agence Europe) - The French Alliance for Rare Diseases, laboratories and research institutes have just launched two new initiatives aimed at stepping up the development of treatments for orphan diseases, which affect 20 million people in Europe.
The first initiative, christened OrphanXchange, aims to promote partnerships between academic research structures and private companies to develop diagnostic solutions and orphan drugs. It relies on a database which is free and...